What we do
The Simcyp Population-based Simulator
The Simcyp Population-based Simulator streamlines drug development through the modelling and simulation of pharmacokinetics and pharmacodynamics in virtual populations. The Simulator is used by the majority of the world’s leading pharmaceutical companies and is the industry’s most sophisticated platform for the prediction of drug-drug interactions and pharmacokinetic outcomes in clinical populations.
Simcyp’s clients form a Consortium which helps guide scientific development at the company, ensuring that our products continue to meet, and exceed, industry needs.
Simcyp maintains strong academic links and our science team conducts internationally recognised cutting-edge research and development. This in-house expertise also allows us to provide high-level scientific and technical support, offer bespoke consultancy services and run education programmes around the world.
